Search

Displaying results 5641 - 5650 of 8010 in total
  1. Drug

    Tiapride

    go.drugbank.com/drugs/DB13025
    Investigational

    Tiapride is a selective D2 and D3 dopamine receptor blocker in the brain.

  2. Drug

    ETC-1001

    go.drugbank.com/drugs/DB05866
    Experimental

    ETC-1001 is Pfizer’s lead oral small molecule product candidate which is intended to be a chronic treatment for individuals with lipid disorders.

  3. Drug

    Vestipitant

    go.drugbank.com/drugs/DB11949
    Investigational

    Vestipitant has been investigated for the treatment of Tinnitus.

  4. Drug

    Enecadin

    go.drugbank.com/drugs/DB13032
    Investigational

    Enecadin has been investigated for the treatment of Stroke.

  5. Drug

    GW-870086

    go.drugbank.com/drugs/DB12322
    Investigational

    GW870086X has been investigated for the treatment of ASTHMA.

  6. Drug

    Ipamorelin

    go.drugbank.com/drugs/DB12370
    Investigational

    Ipamorelin has been investigated for the treatment of Ileus.

  7. Drug

    Modufolin

    go.drugbank.com/drugs/DB12676
    Investigational

    Modufolin is under investigation for the treatment of Osteosarcoma.

  8. Drug

    Inhibitor of P38 Kinase

    go.drugbank.com/drugs/DB01953
    Experimental

    These are compounds containing an indole moiety, which consists of a pyrrole ring fused to benzene to form 2,3-benzopyrrole. This drug is known to target mitogen-activated protein kinase 14.

  9. Drug

    ABT-560

    go.drugbank.com/drugs/DB06093
    Experimental

    ABT-560 is a neuronal nicotinic receptor (NNR) modulator, which has shown promise in preclinical models relevant for the treatment of cognitive deficits.

  10. Drug

    Talinolol

    go.drugbank.com/drugs/DB11770
    Investigational

    Talinolol has been investigated for the basic science of Gastrointestinal Motility Disorder.